The country that's ahead of the curve on chronic disease prevention

MAHA wants to tackle chronic diseases. This country had that idea decades ago.

December 10, 2025 Check out STAT+

Sponsored By

STAT MAHA wants to tackle chronic diseases. This country had that idea decades ago European researchers looking for best practices in primary care are studying Slovenia's health promotion centers and how a focus on prevention gets results. By Andrew Joseph Myocarditis is a rare but real Covid vaccine side effect. A new study sheds light on what might cause it Study points to source of "very rare" cases of myocarditis and offers potential solutions. Myocarditis risk remains far higher from Covid infection than the vaccine. By Jonathan Wosen Sperm donor with rare cancer-causing mutation fathers nearly 200 children across Europe A sperm donor with a cancer-causing gene variant fathered nearly 200 children across Europe, according to an investigation by 14 European news organizations. By Andrew Joseph STAT Opinion: The revolution in dementia care is just beginning Jason Karlawish on how diagnostics and treatment for Alzheimer's and other causes of dementia are changing completely. By Torie Bosch STAT+ | Top HHS official evades discussing Trump plan to block state AI laws Deputy health secretary Jim O'Neill demurred when asked about a controversial proposal to prevent states from enforcing local laws on artificial intelligence. By Mario Aguilar STAT+ | Major health insurers to skip J.P. Morgan conference, again High costs, quiet-period rules, investor skepticism, and lingering safety concerns are pushing major insurers to once again skip JPM's flagship event. By Tara Bannow and Bob Herman Adobe Opinion: Rise of anti-science rhetoric has fundamentally changed the relationship between doctors and patients When clinicians are hesitant to even raise the topic of vaccination, we inch toward a public-health landscape shaped not by science, but by noise. By Krutika Kuppalli STAT+ | In a first, a nonprofit wins FDA approval for rare disease gene therapy The FDA approved a new gene therapy for a rare immune disorder, the maker of which is notably not a drug company, but an Italian charity.  By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser